Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Purchases of Investments
Cash used to buy marketable securities and other investments.
Purchases of Investments history
Currency unavailable · from the cash flow
No Purchases of Investments data reported for this period type.
Purchases of Investments vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.52B USD | +111.8% | +7.5% | 2141.9% | |
| LTM Jun 2026 | $217.05M USD | +12.3% | — | 3048.0% | |
| LTM Mar 2026 | $129.68M USD | +149.3% | +23.6% | — | |
| FY2025 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | +100.0% | — | 0.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +105.9% | +15.5% | 1070.9% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.